DK374289A - Indazol-3-carboxylsyrederivater, deres fremstilling og anvendelse - Google Patents
Indazol-3-carboxylsyrederivater, deres fremstilling og anvendelse Download PDFInfo
- Publication number
- DK374289A DK374289A DK374289A DK374289A DK374289A DK 374289 A DK374289 A DK 374289A DK 374289 A DK374289 A DK 374289A DK 374289 A DK374289 A DK 374289A DK 374289 A DK374289 A DK 374289A
- Authority
- DK
- Denmark
- Prior art keywords
- indazol
- preparation
- carboxylic acid
- acid derivatives
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP19190488 | 1988-07-29 | ||
JP32298688 | 1988-12-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
DK374289D0 DK374289D0 (da) | 1989-07-28 |
DK374289A true DK374289A (da) | 1990-01-30 |
Family
ID=26506977
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK374289A DK374289A (da) | 1988-07-29 | 1989-07-28 | Indazol-3-carboxylsyrederivater, deres fremstilling og anvendelse |
Country Status (11)
Country | Link |
---|---|
US (1) | US5017573A (da) |
EP (1) | EP0358903A3 (da) |
JP (2) | JPH0655738B2 (da) |
KR (1) | KR910002839A (da) |
AU (1) | AU621642B2 (da) |
DK (1) | DK374289A (da) |
FI (1) | FI893592A (da) |
HU (1) | HU204816B (da) |
NO (1) | NO173652C (da) |
NZ (1) | NZ230068A (da) |
PT (1) | PT91287B (da) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9214184D0 (en) * | 1992-07-03 | 1992-08-12 | Smithkline Beecham Plc | Pharmaceuticals |
US5989586A (en) * | 1992-10-05 | 1999-11-23 | Cygnus, Inc. | Two-phase matrix for sustained release drug delivery device |
US5654320A (en) * | 1995-03-16 | 1997-08-05 | Eli Lilly And Company | Indazolecarboxamides |
IL117438A (en) * | 1995-03-16 | 2001-12-23 | Lilly Co Eli | Indazolecarboxamides, their preparation and pharmaceutical compositions containing them |
CA2222532A1 (en) * | 1995-05-31 | 1996-12-05 | Nisshin Flour Milling Co., Ltd. | Indazole derivatives having monocyclic amine |
RU2156248C2 (ru) * | 1995-07-28 | 2000-09-20 | Дайниппон Фармасьютикал Ко., Лтд. | (r)-5-бром-n-(1-этил-4-метилгексагидро-1h-1,4-диазепин-6-ил)-2-метокси-6-м етиламино-3-пиридинкарбоксамид, способ его получения, фармацевтическая композиция и противорвотное средство, содержащее указанное соединение, и его промежуточное соединение |
US6046185A (en) * | 1996-07-11 | 2000-04-04 | Inflazyme Pharmaceuticals Ltd. | 6,7-oxygenated steroids and uses related thereto |
GB9721139D0 (en) | 1997-10-07 | 1997-12-03 | Glaxo Group Ltd | Medicaments |
US6069152A (en) * | 1997-10-07 | 2000-05-30 | Eli Lilly And Company | 5-HT4 agonists and antagonists |
US5914405A (en) * | 1997-10-07 | 1999-06-22 | Eli Lilly And Company | Process for preparing 3-substituted indazoles |
DE10041478A1 (de) * | 2000-08-24 | 2002-03-14 | Sanol Arznei Schwarz Gmbh | Neue pharmazeutische Zusammensetzung |
WO2003035005A2 (en) * | 2001-10-26 | 2003-05-01 | University Of Connecticut | Heteroindanes: a new class of potent cannabimimetic ligands |
TW200533348A (en) * | 2004-02-18 | 2005-10-16 | Theravance Inc | Indazole-carboxamide compounds as 5-ht4 receptor agonists |
US7728006B2 (en) * | 2004-04-07 | 2010-06-01 | Theravance, Inc. | Quinolinone-carboxamide compounds as 5-HT4 receptor agonists |
US8309575B2 (en) | 2004-04-07 | 2012-11-13 | Theravance, Inc. | Quinolinone-carboxamide compounds as 5-HT4 receptor agonists |
TWI351282B (en) * | 2004-04-07 | 2011-11-01 | Theravance Inc | Quinolinone-carboxamide compounds as 5-ht4 recepto |
TW200621237A (en) | 2004-11-01 | 2006-07-01 | Wyeth Corp | [(1-h-indazol-3-yl)methyl]phenols and (hydroxyphenyl)(1h-indazol-3-yl)methanones |
ES2332808T3 (es) * | 2004-11-05 | 2010-02-12 | Theravance, Inc. | Compuestos agonistas del receptor 5-ht4. |
JP5042028B2 (ja) * | 2004-11-05 | 2012-10-03 | セラヴァンス, インコーポレーテッド | キノリノン−カルボキサミド化合物 |
US7419989B2 (en) * | 2004-12-22 | 2008-09-02 | Theravance, Inc. | Indazole-carboxamide compounds |
BRPI0608392A2 (pt) * | 2005-03-02 | 2009-12-29 | Theravance Inc | compostos de quinolinona como agonistas do receptor 5-ht4 |
EP2253316B1 (en) | 2009-05-20 | 2013-08-14 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Serotonin 5-HT3 receptor antagonists for use in the treatment or prevention of an inner ear pathology with vestibular deficits |
CN102458400B (zh) | 2009-05-20 | 2014-10-08 | 国立健康与医学研究所 | 用于治疗病灶性前庭功能障碍的血清素5-ht3受体拮抗剂 |
JOP20130213B1 (ar) | 2012-07-17 | 2021-08-17 | Takeda Pharmaceuticals Co | معارضات لمستقبلht3-5 |
GB201511382D0 (en) | 2015-06-29 | 2015-08-12 | Imp Innovations Ltd | Novel compounds and their use in therapy |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1069122A (en) * | 1975-11-11 | 1980-01-01 | W.R. Grace And Co. | Preparation of dialkali metal hexahydropyrimidine-1, 3-diacetate and dialkalimetal 5-hydroxyhexahydropyrimidine-1, 3-diacetate |
JPS5925785B2 (ja) * | 1976-01-01 | 1984-06-21 | 山之内製薬株式会社 | 新規なカルボン酸アミド誘導体 |
US4207327A (en) * | 1977-08-19 | 1980-06-10 | A. H. Robins Company, Inc. | N-(4-Pyrazolidinyl)benzamides and their amino precursors |
EP0049779B1 (en) * | 1980-09-18 | 1984-10-31 | Asahi Kasei Kogyo Kabushiki Kaisha | 3-aminoindazole derivatives and process for preparation thereof |
CA1220141A (en) * | 1981-06-13 | 1987-04-07 | John R. Fozard | Treatment of migraine with tropyl benzoate derivatives |
FR2531083B1 (fr) * | 1982-06-29 | 1986-11-28 | Sandoz Sa | Nouveaux derives de la piperidine, leur preparation et leur utilisation comme medicaments |
JPS60123485A (ja) * | 1983-12-08 | 1985-07-02 | Yoshitomi Pharmaceut Ind Ltd | インド−ル−3−カルボキサミド誘導体 |
ATE61054T1 (de) * | 1985-01-23 | 1991-03-15 | Hoechst Roussel Pharma | 3-piperidinyl- 1h-indazole, verfahren zu deren herstellung und deren anwendung als arzneimittel. |
GB8623142D0 (en) * | 1986-09-26 | 1986-10-29 | Beecham Group Plc | Compounds |
DE3650772T2 (de) * | 1985-04-27 | 2003-04-03 | F. Hoffmann-La Roche Ag, Basel | Derivate von Indazole-3-carboxamide und -3-carboxylsäure |
GB8520616D0 (en) * | 1985-08-16 | 1985-09-25 | Beecham Group Plc | Compounds |
GB8527052D0 (en) * | 1985-11-02 | 1985-12-04 | Beecham Group Plc | Compounds |
ES2053451T3 (es) * | 1986-01-07 | 1994-08-01 | Beecham Group Plc | Un procedimiento para la preparacion de un compuesto que tiene propiedades farmacologicas utiles. |
EP0235878A3 (en) * | 1986-01-16 | 1989-06-14 | Beecham Group Plc | Novel compounds |
DE3822792C2 (de) * | 1987-07-11 | 1997-11-27 | Sandoz Ag | Neue Verwendung von 5HT¶3¶-Antagonisten |
JPH01117860A (ja) * | 1987-10-30 | 1989-05-10 | Dainippon Pharmaceut Co Ltd | 安息香酸アミド誘導体 |
EP0410509A1 (en) * | 1989-07-25 | 1991-01-30 | Duphar International Research B.V | New substituted 1H-indazole-3-carboxamides |
US4954503A (en) * | 1989-09-11 | 1990-09-04 | Hoechst-Roussel Pharmaceuticals, Inc. | 3-(1-substituted-4-piperazinyl)-1H-indazoles |
-
1989
- 1989-07-25 US US07/384,766 patent/US5017573A/en not_active Expired - Fee Related
- 1989-07-25 NZ NZ230068A patent/NZ230068A/en unknown
- 1989-07-26 PT PT91287A patent/PT91287B/pt not_active IP Right Cessation
- 1989-07-26 EP EP19890113776 patent/EP0358903A3/en not_active Withdrawn
- 1989-07-27 JP JP1196351A patent/JPH0655738B2/ja not_active Expired - Lifetime
- 1989-07-27 HU HU893824A patent/HU204816B/hu not_active IP Right Cessation
- 1989-07-27 FI FI893592A patent/FI893592A/fi not_active Application Discontinuation
- 1989-07-27 KR KR1019890010658A patent/KR910002839A/ko not_active Application Discontinuation
- 1989-07-28 NO NO893078A patent/NO173652C/no unknown
- 1989-07-28 AU AU39103/89A patent/AU621642B2/en not_active Ceased
- 1989-07-28 DK DK374289A patent/DK374289A/da not_active Application Discontinuation
-
1992
- 1992-01-31 JP JP4046294A patent/JP2898139B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
NO173652C (no) | 1994-01-12 |
DK374289D0 (da) | 1989-07-28 |
HUT52093A (en) | 1990-06-28 |
JPH0655738B2 (ja) | 1994-07-27 |
JPH02256670A (ja) | 1990-10-17 |
NO893078D0 (no) | 1989-07-28 |
EP0358903A3 (en) | 1992-03-04 |
JPH0592959A (ja) | 1993-04-16 |
HU204816B (en) | 1992-02-28 |
KR910002839A (ko) | 1991-02-26 |
FI893592A0 (fi) | 1989-07-27 |
JP2898139B2 (ja) | 1999-05-31 |
AU3910389A (en) | 1990-02-01 |
NZ230068A (en) | 1991-07-26 |
AU621642B2 (en) | 1992-03-19 |
EP0358903A2 (en) | 1990-03-21 |
PT91287B (pt) | 1995-03-01 |
PT91287A (pt) | 1990-02-08 |
US5017573A (en) | 1991-05-21 |
NO893078L (no) | 1990-01-30 |
NO173652B (no) | 1993-10-04 |
FI893592A (fi) | 1990-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK374389A (da) | Arylbenzenoxazolidinoner, deres fremstilling og anvendelse | |
DK609489D0 (da) | Imidazolderivater, deres fremstilling og anvendelse | |
DK374289A (da) | Indazol-3-carboxylsyrederivater, deres fremstilling og anvendelse | |
DK605489A (da) | Beta-amino-boronsyre-derivater, deres fremstilling og anvendelse | |
NO892745D0 (no) | Aminoalkylaminokarbonylaminodiolaminosyrederivater og fremgangsmaate for deres fremstilling. | |
DK399789D0 (da) | Annellerede tetrahydropyridineddikesyrederivater, deres fremstilling og anvendelse | |
DK595388A (da) | Benzopyranderivater, deres fremstilling og anvendelse | |
DK388989A (da) | Acylcyanoguanidiner, deres fremstilling og anvendelse | |
DK193088A (da) | 2-acylpyrrolidin-derivater, deres fremstilling og anvendelse | |
DK633287D0 (da) | Carbamoylimidazo-derivater, deres fremstilling og anvendelse | |
DK278188D0 (da) | Thiazolidin-4-on-derivater, deres fremstilling og anvendelse | |
DK235787D0 (da) | Tripeptidderivater, deres fremstilling og anvendelse | |
DK225089A (da) | 2-adamantyl-4-isothiazolin-3-oner, deres fremstilling og anvendelse | |
DK189488A (da) | Imidazothiadiazinderivater, deres fremstilling og anvendelse | |
DK469389D0 (da) | Piperidinyl-imidazol-derivater, deres fremstilling og anvendelse | |
DK213387D0 (da) | Benzothiazinon-derivater, deres fremstilling og anvendelse | |
DK212687A (da) | Benzothiazinon-derivater, deres fremstilling og anvendelse | |
DK223288A (da) | Benzensulfornamid-derivater, deres fremstilling og anvendelse | |
DK610787A (da) | Substituerede thienoimidazoltoluidin-derivater, deres fremstilling og anvendelse | |
DK548586A (da) | Thienylsulfonylguanidin-derivater, deres fremstilling og anvendelse | |
DK412188A (da) | Benzothiazinon-derivater, deres fremstilling og anvendelse | |
DK361388A (da) | Cephemderivater, deres fremstilling og anvendelse | |
DK613888D0 (da) | Acyllabdan-derivater, deres fremstilling og anvendelse | |
DK668888D0 (da) | Labdan-derivater, deres fremstilling og anvendelse | |
DK668788D0 (da) | Labdanderivater, deres fremstilling og anvendelse |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHB | Application shelved due to non-payment |